Yuhan Wei

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Distinct immune microenvironment in HER2-low triple-negative breast cancer underlies inferior response to immunotherapy.

Distinct immune microenvironment in HER2-low triple-negative breast cancer underlies inferior response to immunotherapy.

Journal: NPJ precision oncology

Published: January 23, 2026

Low-Dose Antiangiogenic Therapy With Different Chemotherapy Backbones Among Patients With Heavily Pretreated Metastatic Breast Cancer.

Low-Dose Antiangiogenic Therapy With Different Chemotherapy Backbones Among Patients With Heavily Pretreated Metastatic Breast Cancer.

Journal: Cancer innovation

Published: August 25, 2025

Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patients.

Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patients.

Journal: Communications medicine

Published: May 14, 2025

Novel Causal Evidence for the Role of Circulating Lipid Metabolites in Breast Cancer Risk: A Bidirectional Mendelian Randomization Analysis.

Novel Causal Evidence for the Role of Circulating Lipid Metabolites in Breast Cancer Risk: A Bidirectional Mendelian Randomization Analysis.

Journal: Journal of nutrition and metabolism

Published: March 08, 2025

Multi-cohort validation of a lipid metabolism and ferroptosis-associated index for prognosis and immunotherapy response prediction in hormone receptor-positive breast cancer.

Multi-cohort validation of a lipid metabolism and ferroptosis-associated index for prognosis and immunotherapy response prediction in hormone receptor-positive breast cancer.

Journal: International journal of biological sciences

Published: March 04, 2025

Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancer.

Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancer.

Journal: Journal of autoimmunity

Published: January 30, 2025

Biologically-informed integration of drug representations for breast cancer treatment using deep learning.

Biologically-informed integration of drug representations for breast cancer treatment using deep learning.

Journal: Nature communications

Published: November 13, 2024

Training and experimental validation a novel anoikis- and epithelial‒mesenchymal transition-related signature for evaluating prognosis and predicting immunotherapy efficacy in gastric cancer.

Training and experimental validation a novel anoikis- and epithelial‒mesenchymal transition-related signature for evaluating prognosis and predicting immunotherapy efficacy in gastric cancer.

Journal: Journal of Cancer

Published: October 30, 2024

Relationship between 21 Medications and Negative Emotions: A Mendelian Randomization Analysis in Asian Populations.

Relationship between 21 Medications and Negative Emotions: A Mendelian Randomization Analysis in Asian Populations.

Journal: Current medicinal chemistry

Published: October 08, 2024

Predictive circulating biomarkers of the response to anti-PD-1 immunotherapy in advanced HER2 negative breast cancer.

Predictive circulating biomarkers of the response to anti-PD-1 immunotherapy in advanced HER2 negative breast cancer.

Journal: Clinical and translational medicine

Published: September 27, 2024

Meta-analysis reveals pathological complete response benefits from neoadjuvant immuno-chemotherapy combination in patients with HER2-negative breast cancer.

Meta-analysis reveals pathological complete response benefits from neoadjuvant immuno-chemotherapy combination in patients with HER2-negative breast cancer.

Journal: BMC cancer

Published: September 04, 2024

Integrated bulk and single-cell transcriptomic analysis unveiled a novel cuproptosis-related lipid metabolism gene molecular pattern and a risk index for predicting prognosis and antitumor drug sensitivity in breast cancer.

Integrated bulk and single-cell transcriptomic analysis unveiled a novel cuproptosis-related lipid metabolism gene molecular pattern and a risk index for predicting prognosis and antitumor drug sensitivity in breast cancer.

Journal: Discover oncology

Published: August 21, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026